Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Cash & Equivalents: 2009-2025

Historic Revenue - Interest and Investment Income for INNOVATE (VATE) over the last 1 years, with Dec 2010 value amounting to $1.5 billion.

  • INNOVATE's Cash & Equivalents fell 30.39% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.5 million, marking a year-over-year decrease of 30.39%. This contributed to the annual value of $48.8 million for FY2024, which is 39.60% down from last year.
  • Per INNOVATE's latest filing, its Cash & Equivalents stood at $35.5 million for Q3 2025, which was up 6.29% from $33.4 million recorded in Q2 2025.
  • In the past 5 years, INNOVATE's Cash & Equivalents ranged from a high of $80.8 million in Q4 2023 and a low of $16.6 million during Q1 2023.
  • For the 3-year period, INNOVATE's Cash & Equivalents averaged around $45.7 million, with its median value being $38.4 million (2024).
  • Data for INNOVATE's Revenue - Interest and Investment Income shows a peak YoY skyrocketed of 145.51% (in 2010) over the last 5 years.
  • Over the past 2 years, INNOVATE's Revenue - Interest and Investment Income (Quarterly) stood at $1.4 billion in 2009, then rose by 8.06% to $1.5 billion in 2010.
  • Its Cash & Equivalents stands at $35.5 million for Q3 2025, versus $33.4 million for Q2 2025 and $33.3 million for Q1 2025.